FUT3 expression in human breast cancer cells under hypoxia and serum deprivation
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13727Keywords:
breast cancer, FUT3, hypoxic microenvironment, serum deprivationAbstract
Summary. This study aimed to investigate the effects of hypoxia and serum deprivation on regulation of fucosyltransferase-3 (FUT3) expression in breast cancer cells. Materials and Methods: FUT3 expression was evaluated in T47D and MCF7 cells. Transcriptional and protein analysis was performed under hypoxia and serum deprivation conditions after 6 and 24 hours; and after 24 and 48 hours, respectively. Results: In T47D cells, experimental conditions induced a significant decrease in FUT3 expression at both, transcriptional and protein levels, while in MCF7 cells the same conditions induced a significant increase of FUT3 expression. Conclusions: Regulation of FUT3 expression under hypoxic and serum deprivation conditions may be involved in the acquisition of advantages related to apoptosis resistance and metastasis promotion, according to the intrinsic differences presented by T47D and MCF7 cells.
References
Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646–64.
Jung S, Li C, Duan J, et al. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition. Oncotarget 2015; 30: 29060–75.
Li C, Jung S, Yang Y, et al. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines. Int J Oncol 2016; 48: 2639–46.
Semenza GL. Hypoxia-inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype. EMBO J 2017; 3: 252–9.
Greville G, McCann A, Rudd P, et al. Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics 2016; 11: 845–57.
Peixoto A, Fernandes E, Gaiteiro C, et al. Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension. Oncotarget 2016; 7: 63138–57.
Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 2015; 15: 540–55.
Hirakawa M, Takimoto R, Tamura F, et al. Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br J Cancer 2014; 110: 156–63.
Breiman A, López Robles MD, de Carné Trécesson S, et al. Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin). Oncotarget 2016; 12: 14064–82.
Yadav A, Kumar B, Yu JG, et al. Tumor-associated endothelial cells promote tumor metastasis by chaperoning circulating tumor cells and protecting them from anoikis. PLoS One 2015; 10: e0141602.
Higai K, Ichikawa A, Matsumoto K. Binding of sialyl Lewis X antigen to lectin-like receptors on NK cells induces cytotoxicity and tyrosine phosphorylation of a 17-kDa protein. Biochim Biophys Acta Gen Subj 2006; 1760: 1355–63.
Wagner KW, Punnoose EA, Januario T, et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the pro apoptotic ligand Apo2L/TRAIL. Nat Med 2007; 13: 1070–7.
Potapenko IO, Lüders T, Russnes HG, et al. Glycan-related gene expression signatures in breast cancer subtypes; relation to survival. Mol Oncol 2015; 4: 861–76.
Julien S, Ivetic A, Grigoriads A, et al. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 2011; 24: 7683–93.
Shirure VS, Liu T, Delgadillo LF, et al. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands underflow conditions. Am J Physiol Cell Physiol 2015; 1: C68–C78.
Nascimento JC, Ferreira SA, Vasconcelos JL, et al. Fut3 role in breast invasive ductal carcinoma: Investigating its gene promoter and protein expression. Exp Mol Pathol 2015; 3: 409–15.
Kölbl AC, Hiller RA, Ilmer M, et al. Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumor cells from blood samples of patients with breast cancer undergoing adjuvant therapy. Mol Med Rep 2015; 2: 2933–8.
Kao J, Salari K, Bocanegra M, et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009; 7: e61146.
Yin S, Rishi AK, Reddy KB. Anti-estrogen‑resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment. Oncol Rep 2015; 3: 1475–8.
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 v1.0. IARC Cancer Base 2019; (11) [Internet].
Wang W, He YF, Sun QK, et al. Hypoxia-inducible factor 1α in breast cancer prognosis. Clin Chim Acta 2014; 428: 32–7.
Wi GR, Moon, BI, Kim, HJ, et al. A lectin-based approach to detecting carcinogenesis in breast tissue. Oncol Lett 2016; 11: 3889–95.
Dai X, Cheng H, Bai Z, et al. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer 2017; 16: 3131–41.
Yde CW, Gyrd-Hansen M, Lykkesfeldt AE, et al. Breast cancer cells with acquired antiestrogen resistance are sensitized to cisplatin-induced cell death. Mol Cancer Ther 2007; 6: 1869–76.
Yin S, Sethi S, Reddy KB. Protein kinase Cδ and caspase-3 modulate TRAIL-induced apoptosis in breast tumor cells. J Cell Biochem 2010; 111: 979–87.
Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999; 5: 157–63.
Knoll G, Bittner S, Kurz M, et al. Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy. Oncotarget 2016; 27: 41488–504.
Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 2006; 7: 988–94.
Silke J, Hawkins CJ, Ekert PG, et al. The anti-apoptotic activity of XIAP is retained upon mutation of both the caspase 3- and caspase 9-interacting sites. J Cell Biol 2002; 157: 115–24.
Desiderio V, Papagerakis P, Tirino V, et al. Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells. Oncotarget 2015; 1: 71–84.
Azijli K, Weyhenmeyer B, Peters GJ, et al. Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family. Cell Death Differ 2013; 20: 858–68.
Brint E, O’Callaghan G, Houston A. Life in the Fas lane: differential outcomes of Fas signaling. Cell Mol Life Sci 2013; 70: 4085–99.
Koike T, Kimura N, Miyazaki K, et al. Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A 2004; 21: 8132–7.
Potapenko IO, Haakensen VD, Luders T, et al. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol Oncol 2010; 4: 98e118.
Ashkani J, Naidoo KJ. Glycosyltransferase gene expression profiles classify cancer types and propose prognostic subtypes. Sci Rep 2016; 6: 26451.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
